Birchview Capital, Lp Top Holdings and 13F Report (2024) About Birchview Capital, LpInvestment ActivityBirchview Capital, Lp has $115.22 million in total holdings as of September 30, 2024.Birchview Capital, Lp owns shares of 62 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 14.34% of the portfolio was purchased this quarter.About 11.80% of the portfolio was sold this quarter.This quarter, Birchview Capital, Lp has purchased 61 new stocks and bought additional shares in 10 stocks.Birchview Capital, Lp sold shares of 7 stocks and completely divested from 4 stocks this quarter.Largest Holdings Bristol-Myers Squibb $35,503,045Biodesix $9,589,702ACADIA Pharmaceuticals $6,158,152Elutia $5,033,829United Therapeutics $3,583,500 Largest New Holdings this Quarter EQT $1,268,440 HoldingTreace Medical Concepts $396,430 HoldingBlueprint Medicines $249,750 HoldingALUMIS INC $106,800 HoldinguniQure $98,600 Holding Largest Purchases this Quarter Biodesix 5,233,770 shares (about $9.32M)ACADIA Pharmaceuticals 150,000 shares (about $2.31M)EQT 34,619 shares (about $1.27M)Castle Biosciences 24,000 shares (about $684.48K)Alphatec 110,000 shares (about $611.60K) Largest Sales this Quarter Harrow 77,090 shares (about $3.47M)Neurocrine Biosciences 12,000 shares (about $1.38M)Elutia 230,440 shares (about $877.98K)Ovintiv 22,000 shares (about $842.82K)Bristol-Myers Squibb 2,036 shares (about $105.34K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBirchview Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorBMYBristol-Myers Squibb$35,503,045$105,343 ▼-0.3%686,18230.8%MedicalBDSXBiodesix$9,589,702$9,316,111 ▲3,405.1%5,387,4738.3%MedicalACADACADIA Pharmaceuticals$6,158,152$2,307,000 ▲59.9%400,4005.3%MedicalELUTElutia$5,033,829$877,976 ▼-14.9%1,321,2154.4%MedicalUTHRUnited Therapeutics$3,583,5000.0%10,0003.1%MedicalPRTAProthena$3,506,173$100,380 ▲2.9%209,5743.0%MedicalNBIXNeurocrine Biosciences$3,484,253$1,382,640 ▼-28.4%30,2403.0%MedicalCORTCorcept Therapeutics$3,424,7200.0%74,0003.0%MedicalHROWHarrow$3,278,034$3,465,967 ▼-51.4%72,9102.8%MedicalQUIDELORTHO CORP$3,083,4260.0%67,6192.7%COMFHTXFoghorn Therapeutics$2,987,8580.0%320,9302.6%MedicalAXGNAxoGen$2,761,9400.0%197,0002.4%MedicalPHRPhreesia$2,614,0130.0%114,7002.3%MedicalSTOKStoke Therapeutics$2,580,9000.0%210,0002.2%MedicalPTGXProtagonist Therapeutics$2,160,0000.0%48,0001.9%MedicalTVTXTravere Therapeutics$2,070,520$363,740 ▲21.3%148,0001.8%MedicalMASIMasimo$2,037,2820.0%15,2801.8%MedicalOVVOvintiv$1,999,782$842,820 ▼-29.6%52,2001.7%Oils/EnergyDCGODocGo$1,709,800$182,600 ▲12.0%515,0001.5%MedicalCSTLCastle Biosciences$1,654,160$684,480 ▲70.6%58,0001.4%MedicalALKSAlkermes$1,399,5000.0%50,0001.2%MedicalEQTEQT$1,268,440$1,268,440 ▲New Holding34,6191.1%Oils/EnergyATECAlphatec$1,100,880$611,600 ▲125.0%198,0001.0%MedicalKALVKalVista Pharmaceuticals$949,560$416,880 ▲78.3%82,0000.8%MedicalKNSAKiniksa Pharmaceuticals$749,7000.0%30,0000.7%MedicalTXG10x Genomics$677,4000.0%30,0000.6%MedicalHALOHalozyme Therapeutics$572,4000.0%10,0000.5%MedicalACCELERATE DIAGNOSTICS INC$556,1580.0%325,2390.5%COMCYTKCytokinetics$528,0000.0%10,0000.5%MedicalINHIBRX BIOSCIENCES INC$502,843$313,200 ▲165.2%32,1100.4%COMKROSKeros Therapeutics$406,4900.0%7,0000.4%MedicalAPLSApellis Pharmaceuticals$403,7600.0%14,0000.4%MedicalTMCITreace Medical Concepts$396,430$396,430 ▲New Holding68,3500.3%MedicalXENEXenon Pharmaceuticals$393,7000.0%10,0000.3%MedicalKPTIKaryopharm Therapeutics$389,9610.0%469,8320.3%MedicalCHRSCoherus BioSciences$386,880$106,080 ▲37.8%372,0000.3%MedicalARVNArvinas$369,4500.0%15,0000.3%MedicalPGNYProgyny$368,7200.0%22,0000.3%MedicalBIOHAVEN PHARMACEUTICAL HOLDING CO LTD$368,0290.0%7,3650.3%COMAXSMAxsome Therapeutics$359,4800.0%4,0000.3%MedicalCGEMCullinan Therapeutics$334,8000.0%20,0000.3%MedicalWVEWave Life Sciences$328,0000.0%40,0000.3%MedicalSWTXSpringWorks Therapeutics$320,4000.0%10,0000.3%MedicalNVCRNovoCure$312,6000.0%20,0000.3%MedicalSRPTSarepta Therapeutics$312,2250.0%2,5000.3%MedicalBCRXBioCryst Pharmaceuticals$304,0000.0%40,0000.3%MedicalFOLDAmicus Therapeutics$299,0400.0%28,0000.3%MedicalBDSXBiodesix$265,3840.0%153,7030.2%MedicalBPMCBlueprint Medicines$249,750$249,750 ▲New Holding2,7000.2%MedicalXNCRXencor$247,3530.0%12,3000.2%MedicalGOSSGossamer Bio$136,2970.0%138,1760.1%MedicalBLUEbluebird bio$109,718$51,950 ▼-32.1%211,2000.1%MedicalALUMIS INC$106,800$106,800 ▲New Holding10,0000.1%COMLQDALiquidia$100,0000.0%10,0000.1%MedicalQUREuniQure$98,600$98,600 ▲New Holding20,0000.1%MedicalIFRXInflaRx$76,5000.0%50,0000.1%MedicalTSVT2seventy bio$74,732$9,440 ▼-11.2%15,8330.1%MedicalVTYXVentyx Biosciences$62,7840.0%28,8000.1%MedicalZNTLZentalis Pharmaceuticals$58,8800.0%16,0000.1%MedicalCABACabaletta Bio$47,2000.0%10,0000.0%MedicalOMOutset Medical$6,7700.0%10,0000.0%MedicalPBAXPhoenix Biotech Acquisition$1,2100.0%12,9720.0%UnclassifiedSILKSilk Road Medical$0$4,274,862 ▼-100.0%00.0%MedicalETRNEquitrans Midstream$0$1,726,989 ▼-100.0%00.0%Oils/EnergyXOMExxon Mobil$0$673,332 ▼-100.0%00.0%Oils/EnergyGTHXG1 Therapeutics$0$182,400 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
